Company Profile
Hoth Therapeutics Stock Price, News & Catalysts
- Ticker:
- HOTH
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
1.36 USD (+92.01%)
Close
Last updated: May 27, 2026
26M USD
Market cap
Why the stock is moving
Current closing-price context is not available for HOTH.
Company overview
Technology Company with Legacy Biotech Assets
Rocket One, formerly Hoth Therapeutics, has shifted its primary strategy toward advanced computing and semiconductor technologies while retaining selected biotechnology programs in a subsidiary.
Spintronic Computing Strategy
The company is pursuing spintronic and related semiconductor technologies intended for data-center, defense, and space applications. These technologies seek to improve computing performance and energy efficiency through new device architectures.
Intellectual Property and Partnership Model
Rocket One evaluates licensed intellectual property, research collaborations, and strategic investments rather than operating a large internal manufacturing footprint. Commercial value would depend on technical validation and partner adoption.
Legacy HT-001 Program
The retained biotechnology portfolio includes HT-001, a topical candidate previously developed for skin toxicities associated with cancer treatment. Other legacy assets have addressed oncology and neurological indications.
Corporate Transformation
The filing reflects a company transitioning away from a traditional clinical-stage biotechnology identity. Capital allocation, management expertise, and future operations are increasingly centered on computing technology.
Future catalysts
Recent news
- 01
- 02
- 03
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Hoth Therapeutics (HOTH)?
Hoth Therapeutics (HOTH) most recently closed at 1.36 USD, a +92.01% move versus the previous session.
What is the market cap of Hoth Therapeutics (HOTH)?
Hoth Therapeutics currently has a market capitalization of 26M USD on BioPharmSignal.
What does Hoth Therapeutics do?
Technology Company with Legacy Biotech Assets Rocket One, formerly Hoth Therapeutics, has shifted its primary strategy toward advanced computing and semiconductor technologies while retaining selected biotechnology programs in a subsidiary. Spintronic Computing Strategy The company is pursuing spintronic and related semiconductor technologies intended for...
On which exchange is HOTH stock listed?
Hoth Therapeutics (HOTH) is associated with NASDAQ, United States, Biopharma.
What is HT-001?
Legacy HT-001 Program The retained biotechnology portfolio includes HT-001, a topical candidate previously developed for skin toxicities associated with cancer treatment.
Which conditions is Hoth Therapeutics targeting with HT-001?
Hoth Therapeutics is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
What is Technology?
Technology Company with Legacy Biotech Assets Rocket One, formerly Hoth Therapeutics, has shifted its primary strategy toward advanced computing and semiconductor technologies while retaining selected biotechnology programs in a subsidiary.
What is Legacy?
Technology Company with Legacy Biotech Assets Rocket One, formerly Hoth Therapeutics, has shifted its primary strategy toward advanced computing and semiconductor technologies while retaining selected biotechnology programs in a subsidiary.